HTL's raw material is formulated in many pharmaceutical and medical device products on the world market.
HTL is consistently making investments in R&D to improve the quality of its raw materials as well as to develop new raw materials (for example: HA oligosaccharides production).
HTL?s R&D Department puts its technology and competence in the hands of its clients by being able to supply tailor made HA to fit any particular need.
Our Production and Quality System follows the cGMP for the manufacture of pharmaceutical active ingredients (ICH Q7A) which assures the product supply with constant quality controls and validated methods.
Fabrication de hyaluronate de sodium.
International exhibition on pharmaceutical ingredients and intermediates
13/10/2020 - 15/10/2020
International pharmaceutical industry trade fair
25/11/2020 - 27/11/2020
Location IEC - India Expo Centre